Hoskin P, Lee M, Dunkley D, Danh M, et al. Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres. BMC Cancer 2024;24:702.
PMID: 38849715